Mechanisms of breast cancer metastasis: the role of extracellular matrix
- PMID: 39652293
- DOI: 10.1007/s11010-024-05175-x
Mechanisms of breast cancer metastasis: the role of extracellular matrix
Abstract
The components of the extracellular matrix (ECM) are dynamic, and they mediate mechanical signals that modulate cellular behaviors. Disruption of the ECM can induce the migration and invasion of cancer cells via specific signaling pathways and cytokines. Metastasis is a leading cause of high mortality in malignancies, and early intervention can improve survival rates. However, breast cancer is frequently diagnosed subsequent to metastasis, resulting in poor prognosis and distant metastasis poses substantial hurdles in therapy. In breast cancer, there is notable tissue remodeling of ECM proteins, with several identified as essential components for metastasis. Moreover, specific ECM molecules, receptors, enzymes, and various signaling pathways play crucial roles in breast cancer metastasis, drug treatment, and resistance. The in-depth consideration of these elements could provide potential therapeutic targets to enhance the survival rates and quality of life for breast cancer patients. This review explores the mechanisms by which alterations in the ECM contribute to breast cancer metastasis and discusses current clinical applications targeting ECM in breast cancer treatment, offering valuable perspectives for future ECM-based therapies.
Keywords: Breast cancer; ECM; Extracellular matrix; Mechanisms; Metastasis.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests.
Similar articles
-
Extracellular matrix components in breast cancer progression and metastasis.Breast. 2013 Aug;22 Suppl 2:S66-72. doi: 10.1016/j.breast.2013.07.012. Breast. 2013. PMID: 24074795 Review.
-
Novel mechanism for OSM-promoted extracellular matrix remodeling in breast cancer: LOXL2 upregulation and subsequent ECM alignment.Breast Cancer Res. 2021 May 19;23(1):56. doi: 10.1186/s13058-021-01430-x. Breast Cancer Res. 2021. PMID: 34011405 Free PMC article.
-
The extracellular matrix in breast cancer.Adv Drug Deliv Rev. 2016 Feb 1;97:41-55. doi: 10.1016/j.addr.2015.12.017. Epub 2015 Dec 30. Adv Drug Deliv Rev. 2016. PMID: 26743193 Review.
-
Distinct phenotypes of cancer cells on tissue matrix gel.Breast Cancer Res. 2020 Jul 31;22(1):82. doi: 10.1186/s13058-020-01321-7. Breast Cancer Res. 2020. PMID: 32736579 Free PMC article.
-
Bi-directional signaling: extracellular matrix and integrin regulation of breast tumor progression.Crit Rev Eukaryot Gene Expr. 2013;23(2):139-57. doi: 10.1615/critreveukargeneexpr.2013006647. Crit Rev Eukaryot Gene Expr. 2013. PMID: 23582036 Free PMC article. Review.
Cited by
-
Spatial multi-omics analysis of tumor-stroma boundary cell features for predicting breast cancer progression and therapy response.Front Cell Dev Biol. 2025 Mar 26;13:1570696. doi: 10.3389/fcell.2025.1570696. eCollection 2025. Front Cell Dev Biol. 2025. PMID: 40206396 Free PMC article.
References
-
- Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin 74:229–263. https://doi.org/10.3322/caac.21834 - DOI - PubMed
-
- Kashyap D, Pal D, Sharma R, Garg VK, Goel N, Koundal D, Zaguia A, Koundal S, Belay A (2022) Global increase in breast cancer incidence: risk factors and preventive measures. BioMed Res Int 2022:9605439. https://doi.org/10.1155/2022/9605439 - DOI - PubMed - PMC
-
- Karim AM, Eun Kwon J, Ali T, Jang J, Ullah I, Lee YG, Park DW, Park J, Jeang JW, Kang SC (2023) Triple-negative breast cancer: epidemiology, molecular mechanisms, and modern vaccine-based treatment strategies. Biochem Pharm 212:115545. https://doi.org/10.1016/j.bcp.2023.115545 - DOI - PubMed
-
- Ibragimova MK, Tsyganov MM, Kravtsova EA, Tsydenova IA, Litviakov NV (2023) Organ-specificity of breast cancer metastasis. Int J Mol Sci. https://doi.org/10.3390/ijms242115625 - DOI - PubMed - PMC
-
- Najafi M, Farhood B, Mortezaee K (2019) Extracellular matrix (ECM) stiffness and degradation as cancer drivers. J Cell Biochem 120:2782–2790. https://doi.org/10.1002/jcb.27681 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical